- $78.20m
- -$8.79m
- $42.31m
- 53
- 94
- 36
- 64
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 28.7 | 32.3 | 31.3 | 31 | 32.3 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 28 | 32.3 | 31.7 | 31.1 | 31.5 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 13.2 | 58.5 | 28.7 | 8.33 | 7.32 |
Provision for Income Taxes | |||||
Net Income After Taxes | 10.2 | 44.6 | 22 | 6.5 | 5.71 |
Net Income Before Extraordinary Items | |||||
Net Income | 10.2 | 44.6 | 22 | 6.5 | 5.71 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 10.2 | 44.6 | 22 | 6.5 | 5.71 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.88 | 13.1 | 6.15 | 1.82 | 1.59 |
Special Dividends per Share |